|
| Training sample | Validation sample (n = 91) |
| All (n = 111) | NOV (n = 26) | OV (n = 85) | P value |
|
| Age (years) [median (range)] | 49 (62) | 52 (52) | 49.5 (63) | 0.3 | 50 (59) |
| Sex (female) [n (%)] | 33 (29.7) | 14 (56) | 19 (22.4) | 0.002 | 35 (38.5) |
| Collateral venous circulation [n (%)] | 24 (21.6) | 4 (15.4) | 20 (23.5) | 0.3 | 5 (5.5) |
| Clinical ascites [n (%)] | 84 (75.7) | 21 (80.8) | 63 (74.1) | 0.3 | 66 (72.5) |
| Total bilirubin (mg/dL) [median (range)] | 17.8 (247) | 13 (248) | 14 (234) | 0.9 | 7 (247) |
| Prothrombin time (%) [median (range)] | 55 (86) | 67 (82) | 56 (86) | 0.2 | 64 (79) |
| Albumin (g/L) [median (range)] | 26 (37) | 25 (29) | 25 (34) | 0.3 | 22 (25) |
| Platelet count (×103/mL) [median (range)] | 930 (404) | 146 (491) | 90 (553) | 0.0001 | 113 (553) |
| Spleen diameter (mm) [median (range)] | 139 (123) | 110 (123) | 136 (124) | 0.002 | 101 (123) |
| Portal vein diameter (mm) [median (range)] | 12.8 (14) | 11.8 (7) | 12 (14) | 0.8 | 10 (8) |
| PC/SD ratio [median (range)] | 651.5 (2523) | 1390 (4921.2) | 642.8 (5530) | 0.0001 | 880 (5530) |
| Child-Pugh score [n (%)] | | | | 0.4 | |
| A | 25 (22.5) | 4 (15.4) | 21 (24.7) | | 18 (19.8) |
| B | 39 (35.1) | 12 (46.2) | 27 (31.8) | | 48 (52.7) |
| C | 47 (42.3) | 10 (38.5) | 37 (43.5) | | 20 (22.0) |
| Oesophageal varices [n (%)] | | | | | |
| No varices | 26 (23.4) | — | — | | 19 (20.9) |
| Stage 1 | 7 (6.3) | — | — | | 12 (13.2) |
| Stage 2 | 54 (48.6) | — | — | | 34 (37.4) |
| Stage 3 | 24 (21.6) | — | — | | 26 (28.6) |
| Aetiologies of cirrhosis [n (%)]a | | | | 0.3 | |
| HBV | 68 (61.3) | 16 (61.5) | 52 (61.2) | | 53 (58.2) |
| HCV | 14 (12.6) | 4 (15.4) | 10 (11.8) | | 14 (15.4) |
| HBV + HCV coinfection | 2 (1.8) | 0 | 2 (20) | | — |
| Alcohol | 23 (20.7) | 6 (23.1) | 17 (20) | | 24 (26.4) |
| Mixed (viral and alcohol) | 4 (3.6) | 0 | 4 (4.7) | | — |
|